Correlation Between NextCure and Abcam PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NextCure and Abcam PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NextCure and Abcam PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NextCure and Abcam PLC, you can compare the effects of market volatilities on NextCure and Abcam PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NextCure with a short position of Abcam PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of NextCure and Abcam PLC.

Diversification Opportunities for NextCure and Abcam PLC

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between NextCure and Abcam is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and Abcam PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcam PLC and NextCure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NextCure are associated (or correlated) with Abcam PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcam PLC has no effect on the direction of NextCure i.e., NextCure and Abcam PLC go up and down completely randomly.

Pair Corralation between NextCure and Abcam PLC

Given the investment horizon of 90 days NextCure is expected to generate 5.35 times less return on investment than Abcam PLC. In addition to that, NextCure is 1.17 times more volatile than Abcam PLC. It trades about 0.02 of its total potential returns per unit of risk. Abcam PLC is currently generating about 0.1 per unit of volatility. If you would invest  1,545  in Abcam PLC on September 13, 2024 and sell it today you would earn a total of  814.00  from holding Abcam PLC or generate 52.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy29.29%
ValuesDaily Returns

NextCure  vs.  Abcam PLC

 Performance 
       Timeline  
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Abcam PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Abcam PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Abcam PLC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

NextCure and Abcam PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NextCure and Abcam PLC

The main advantage of trading using opposite NextCure and Abcam PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NextCure position performs unexpectedly, Abcam PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcam PLC will offset losses from the drop in Abcam PLC's long position.
The idea behind NextCure and Abcam PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Content Syndication
Quickly integrate customizable finance content to your own investment portal
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like